Takeda Pharmaceutical Co Ltd (TSE:4502)
円 5,540 +115 (+2.12%) Market Cap: 8.85 Tn Enterprise Value: 13.26 Tn PE Ratio: 0 PB Ratio: 1.16 GF Score: 66/100

Full Year 2026 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

May 13, 2026 / 10:00AM GMT
Release Date Price: 円5192 (+0.46%)

May 13, 2026 / 10:00AM GMT
Presentation
May 13, 2026 / 10:00AM GMT

=====================
Corporate Participants
=====================
* Christopher David O'Reilly
Takeda Pharmaceutical Co Ltd - Global Head of Investor Relations & Global Finance
* Christophe Weber
Takeda Pharmaceutical Co Ltd - President, Chief Executive Officer, Representative Director
* Julie Kim
Takeda Pharmaceutical Co Ltd - Interim Head of Global Portfolio Division
* Milano Furuta
Takeda Pharmaceutical Co Ltd - Chief Financial Officer, Director
* Andrew Plump
Takeda Pharmaceutical Co Ltd - President of Research & Development, Vice President of Subsidiary, Director
* Rhonda Pacheco
Takeda Pharmaceutical Co Ltd - President of US Business Unit & US Country Head

=====================
Conference Call Participants
=====================
* Shinichiro Muraoka
Morgan Stanley - Analyst
* Hidemaru Yamaguchi
Citi Infrastructure Investments LLC - Analyst
* Michael Nedelcovych
Cowen and Company LLC -

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot